[go: up one dir, main page]

EA201270728A1 - Пуриновые соединения - Google Patents

Пуриновые соединения

Info

Publication number
EA201270728A1
EA201270728A1 EA201270728A EA201270728A EA201270728A1 EA 201270728 A1 EA201270728 A1 EA 201270728A1 EA 201270728 A EA201270728 A EA 201270728A EA 201270728 A EA201270728 A EA 201270728A EA 201270728 A1 EA201270728 A1 EA 201270728A1
Authority
EA
Eurasian Patent Office
Prior art keywords
purine
connections
treating
compound
formula
Prior art date
Application number
EA201270728A
Other languages
English (en)
Other versions
EA020529B1 (ru
Inventor
Питер Чарльз Астлс
Росселла Гвидетти
Адам Ян Сандерсон
Шон Патрик Холлинсхед
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA201270728A1 publication Critical patent/EA201270728A1/ru
Publication of EA020529B1 publication Critical patent/EA020529B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Соединение формулыи фармацевтические композиции для лечения или предотвращения боли.
EA201270728A 2010-03-31 2011-03-28 Пуриновые соединения EA020529B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31952110P 2010-03-31 2010-03-31
PCT/US2011/030131 WO2011123372A1 (en) 2010-03-31 2011-03-28 Purine compounds

Publications (2)

Publication Number Publication Date
EA201270728A1 true EA201270728A1 (ru) 2013-01-30
EA020529B1 EA020529B1 (ru) 2014-11-28

Family

ID=44041625

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201270728A EA020529B1 (ru) 2010-03-31 2011-03-28 Пуриновые соединения

Country Status (14)

Country Link
US (1) US8759360B2 (ru)
EP (1) EP2552921B1 (ru)
JP (1) JP5669926B2 (ru)
KR (1) KR20130000402A (ru)
CN (1) CN102803266B (ru)
AR (1) AR080711A1 (ru)
AU (1) AU2011232841B2 (ru)
BR (1) BR112012024586A2 (ru)
CA (1) CA2795080C (ru)
EA (1) EA020529B1 (ru)
ES (1) ES2552431T3 (ru)
MX (1) MX2012011166A (ru)
TW (1) TW201204365A (ru)
WO (1) WO2011123372A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA104010C2 (en) * 2008-12-18 2013-12-25 Эли Лилли Энд Компани Purine compounds
EP2923734B1 (en) * 2009-03-13 2018-01-10 Katholieke Universiteit Leuven, K.U. Leuven R&D Purine analogues and their use as immunosuppressive agents
UA111640C2 (uk) * 2011-11-08 2016-05-25 Ф. Хоффманн-Ля Рош Аг ПОХІДНІ [1,2,3]ТРИАЗОЛО[4,5-d]ПІРИМІДИНУ ЯК АГОНІСТИ КАНАБІНОЇДНОГО РЕЦЕПТОРА 2
US9067943B2 (en) * 2011-11-25 2015-06-30 Hoffmann-La Roche Inc. [1,2,3]triazolo[4,5-D]pyrimidine derivatives
JP6669743B2 (ja) * 2014-11-07 2020-03-18 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ カンナビノイド受容体２のアゴニストとしてのトリアゾロ［４，５−ｄ］ピリミジン
WO2017181320A1 (en) 2016-04-18 2017-10-26 Eli Lilly And Company Treatment for nonalcoholic steatohepatitis and fibrosis
CN109553622A (zh) * 2017-09-27 2019-04-02 扬子江药业集团有限公司 一种替格瑞洛杂质的制备方法
WO2024017227A1 (zh) * 2022-07-21 2024-01-25 长春金赛药业有限责任公司 取代的稠环大麻素受体化合物及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60260579A (ja) 1984-01-13 1985-12-23 Yoshitomi Pharmaceut Ind Ltd プリン誘導体
US5057517A (en) * 1987-07-20 1991-10-15 Merck & Co., Inc. Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents
NZ225447A (en) 1987-07-20 1991-12-23 Merck & Co Inc Piperazinyl derivatives of purine and purine isosteres and pharmaceutical compositions
TW370529B (en) * 1992-12-17 1999-09-21 Pfizer Pyrazolopyrimidines
WO2003022214A2 (en) 2001-09-06 2003-03-20 Millennium Pharmaceuticals, Inc. Piperazine and homopiperazine compounds
US20030139427A1 (en) 2002-08-23 2003-07-24 Osi Pharmaceuticals Inc. Bicyclic pyrimidinyl derivatives and methods of use thereof
US7129239B2 (en) * 2002-10-28 2006-10-31 Pfizer Inc. Purine compounds and uses thereof
WO2005069865A2 (en) 2004-01-13 2005-08-04 Ambit Biosciences Corporation Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
WO2006128172A2 (en) 2005-05-26 2006-11-30 Synta Pharmaceuticals Corp. Method for treating b cell regulated autoimmune disorders
US8252791B2 (en) * 2008-08-13 2012-08-28 Jenrin Discovery, Inc. Purine compounds as cannabinoid receptor blockers
UA104010C2 (en) * 2008-12-18 2013-12-25 Эли Лилли Энд Компани Purine compounds

Also Published As

Publication number Publication date
AR080711A1 (es) 2012-05-02
MX2012011166A (es) 2012-11-12
EP2552921A1 (en) 2013-02-06
JP2013523740A (ja) 2013-06-17
CN102803266B (zh) 2015-04-01
WO2011123372A1 (en) 2011-10-06
CA2795080C (en) 2014-06-10
EA020529B1 (ru) 2014-11-28
US20110245255A1 (en) 2011-10-06
JP5669926B2 (ja) 2015-02-18
KR20130000402A (ko) 2013-01-02
TW201204365A (en) 2012-02-01
BR112012024586A2 (pt) 2016-05-31
AU2011232841A1 (en) 2012-11-08
AU2011232841B2 (en) 2014-05-08
ES2552431T3 (es) 2015-11-27
US8759360B2 (en) 2014-06-24
CA2795080A1 (en) 2011-10-06
EP2552921B1 (en) 2015-10-07
CN102803266A (zh) 2012-11-28

Similar Documents

Publication Publication Date Title
EA201170832A1 (ru) Пуриновые соединения
JOP20180103A1 (ar) مركب صيدلاني
CR20130045A (es) Compuestos terapéuticos
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
UA108101C2 (xx) Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
IN2014DN10670A (ru)
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
EA201391626A1 (ru) Соединения для ингибирования клеточной пролиферации в egfr-стимулированных типах рака
UA110338C2 (xx) Хімічні сполуки
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
EA201300684A1 (ru) Производные 6-амино-2-фениламино-1н-бензимидазол-5-карбоксамида и их применение в качестве ингибиторов микросомной простагландин-е2-синтазы-1
EA201890239A3 (ru) Фумараты как пролекарства и их применение при лечении различных заболеваний
MY163083A (en) Solid forms of a pharmaceutically active substance
TR201816379T4 (tr) DNA-PK inhibitörleri.
EA201270257A1 (ru) Производные n1-сульфонил-5-фторпиримидинона
MX393345B (es) Composiciones farmaceuticas de moduladores c-met.
UA109010C2 (en) Morpholino pyrividines and their use in therapy
HUE037154T2 (hu) Szubsztituált benzilindazol-származékok mint Bub1 kinázgátlók hiperproliferatív megbetegedések kezelésére
EP2831069A4 (en) ISOXAZOL-beta-lactamase INHIBITORS
MX2012007098A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
IN2015DN00185A (ru)
CR20130539A (es) Triazolopiridinas
MX2013004004A (es) Pirrolidinonas como inhibidores de metionina aminopeptidasa (metap-2).
EA201270728A1 (ru) Пуриновые соединения

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU